Checkpoint Capital L.P. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 1:09 pm Sale |
2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Checkpoint Capital L.P. | 0 0.000% |
-228,032 (Position Closed) |
Filing |
| 2023-06-15 11:57 am Purchase |
2023-06-05 | 13G | Kala Pharmaceuticals, Inc. KALA |
Checkpoint Capital L.P. | 228,032 9.700% |
228,032 (New Position) |
Filing |